Table 1. Descriptive analysis of contextual variables and cognitive scores.
| Minimum | Maximum | Mean | Standard deviation | Normal | Impaired | |
|---|---|---|---|---|---|---|
| Age | 18 | 84 | 51.08 | 17,133 | - | - |
| Education | 0 | 18 | 9.31 | 4,372 | - | - |
| Length of illness | 1 | 38 | 13.92 | 9,696 | - | - |
| MMSE | 16 | 30 | 26.05 | 3,203 | 56.4% (22) | 43.6% (17) |
| MoCA | 10 | 29 | 22.38 | 4,982 | 33.3% (13) | 66.7% (26) |
| PVF | 0 | 63 | 31.00 | 14,220 | 79.5% (31) | 20.5% (8) |
| SVF | 4 | 25 | 16.49 | 5,201 | 87.2% (34) | 12.8% (5) |
| A1-A5 | 15 | 68 | 37.38 | 11,762 | 41.0% (16) | 59.0% (23) |
| A6 | 0 | 15 | 6.77 | 4,055 | 56.4% (22) | 43.6% (17) |
| A7 | 0 | 15 | 6.32 | 4,101 | 43.6% (17) | 56.4% (22) |
| MG-QOL | 0 | 46 | 16.36 | 15,276 | - | - |
| MGCS | 0 | 34 | 11.22 | 8,619 | - | - |
| BDI | 0 | 41 | 12.49 | 11,546 | - | - |
| Epworth | 0 | 22 | 8.21 | 5,447 | 61.5% (24) | 23.1% (9) |
| Medication |
|
|
||||
| Immunomodulators | 51.3 (20) | 48.7 (19) | ||||
| Acetylcholinesterase inhibitors | 92.3 (36) | 7.7 (3) | ||||
| Glucocorticosteroids | 59.0 (23) | 41.0 (16) | ||||
| Antidepressants | 38.5 (15) | 61.5 (24) | ||||
| - |
|
|
||||
| Associated diseases | 74.4 (29) | 25.6 (10) | ||||
| Depressionª | 17.9 (7) | 82.05 (32) | ||||
| Thymoma | 51.2 (20) | 43.5 (17) | ||||
MMSE: Mini-Mental State Examination; MoCA: Montreal Cognitive Assessment; PVF: Phonemic verbal fluency; SVF: semantic verbal fluency; A1-A5: immediate memory; A6: short term memory retention; A7: recent memory; MG-QOL: Myasthenia Gravis - quality of life scale; MGCS: Myasthenia Gravis Composite Scale; BDI: Beck Depression Inventory; ªaccording to medical record.